2 Coronavirus Stocks That Will Keep Winning in 2021
Shares of Moderna (NASDAQ: MRNA) and Abbott Laboratories (NYSE: ABT) both climbed last year due to the companies' potential to combat the coronavirus. Moderna, developer of one of the first coronavirus vaccines, soared more than 400%. Investors bet on the then-clinical stage company and the possibility of it launching its very first product. Abbott, a leader in COVID-19 testing, advanced 26%. Here, investors bet the company would benefit from a growing need for coronavirus testing.
Now, revenue is on the horizon for Moderna and quickly growing at Abbott. Let's take a closer look at why 2021 may be another winning year for these two healthcare companies -- and their shareholders.
Image source: Getty Images.
Source Fool.com
